Munich, Germany

Rainer Kramer

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2014.


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Kramer: Innovator in Prostratin Analog Research

Introduction

Rainer Kramer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of prostratin analogs and related compounds. His work focuses on innovative methods and applications that have the potential to impact therapeutic strategies.

Latest Patents

Rainer Kramer holds a patent for "Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use." This patent encompasses various embodiments that provide for prostratin analogs, bryostatin analogs, and prodrugs of prostratin and its analogs. The methods outlined in the patent detail the synthesis of these compounds and their potential applications in medicine.

Career Highlights

Kramer is affiliated with Leland Stanford Junior University, where he continues to advance his research in the field. His work has garnered attention for its innovative approach to drug development and its implications for treating various diseases.

Collaborations

Throughout his career, Rainer Kramer has collaborated with esteemed colleagues, including Paul A. Wender and Lars V. Heumann. These partnerships have enriched his research and contributed to the advancement of knowledge in medicinal chemistry.

Conclusion

Rainer Kramer is a distinguished inventor whose work in prostratin analogs and related compounds showcases his commitment to innovation in medicinal chemistry. His contributions have the potential to lead to significant advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…